Fig. 5From: Detection and monitoring of hypermethylated RASSF1A in serum from patients with metastatic breast cancerMonitoring of patient A with metastatic breast cancer during therapy. Three panels with serial concentrations of the protein biomarkers CA 15-3, CEA, TPA and the concentrations of hypermethylated RASSF1A Back to article page